Biology subjects

Kleiner, S.

Publications and source records attributed to Kleiner, S..

4 recordsLinked to original sources

bioRxiv2025

Minimally invasive delivery of optical nanosensors using injectable hydrogels

Optimizing treatment plans based on an individuals drug concentration can significantly improve therapeutic outcomes, as drug efficacy is closely linked to its plasma levels. This motivates the development of precise tools for measuring drug concentration in situ. To address this, a minimally invasive optical sensing platform based on preformed, injectable hydrogels that encapsulate near-infrared fluorescent single-walled carbon nanotube (SWCNT) sensors is introduced. DNA-suspended SWCNTs are integrated into self-assembling peptide hydrogels reinforced with natural polysaccharide additives, yielding self-healing, shear-thinning gels that can be injected through a fine needle while maintaining both structural integrity and optical functionality. Using levodopa, the primary treatment for Parkinsons disease, as a model target analyte, the encapsulated SWCNTs exhibit a dose-dependent fluorescence response across physiologically relevant concentrations. Importantly, the SWCNTs within the hydrogel retain their fluorescence response to levodopa following injection, as well as in the presence of serum, and in a subcutaneous tissue phantom that mimics the mechanical and optical scattering properties of soft tissue. These results establish preformed injectable peptide-based hydrogels as a new class of function-preserving materials for the localized deployment of SWCNT optical nanosensors, enabling minimally invasive in situ monitoring of drug levels and offering a potential route toward personalized therapeutic drug monitoring.

bioengineering↗

bioRxiv2021

Muscle-secreted neurturin couples myofiber oxidative metabolism and slow motor neuron identity.

Endurance exercise promotes skeletal muscle vascularization, oxidative metabolism, fiber-type switching, and neuromuscular junction integrity. Importantly, the metabolic and contractile properties of the muscle fiber must be coupled to the identity of the innervating motor neuron (MN). Here, we show that muscle-derived neurturin (NRTN) acts on muscle fibers and MNs to couple their characteristics. Using a muscle-specific NRTN transgenic mouse (HSA-NRTN) and RNA-sequencing of MN somas, we observed that retrograde NRTN signaling promotes a shift towards a slow MN identity. In muscle, NRTN increased capillary density, oxidative capacity, and induced a transcriptional reprograming favoring fatty acid metabolism over glycolysis. This combination of effects on muscle and MNs, makes HSA-NRTN mice lean with remarkable exercise performance and motor coordination. Interestingly, HSA-NRTN mice largely recapitulate the phenotype of mice with muscle-specific expression of its upstream regulator PGC-11. This work identifies NRTN as a myokine that couples muscle oxidative capacity to slow MN identity. HIGHLIGHTSO_LINRTN is a myokine induced by physical exercise. C_LIO_LIMuscle-derived NRTN promotes a slow motor neuron identity. C_LIO_LIMuscle-derived NRTN enhances muscle oxidative metabolism. C_LIO_LINRTN improves systemic metabolism, exercise performance and motor coordination. C_LI

physiology↗

bioRxiv2020

Establishing cell-intrinsic limitations in cell cycle progression controls graft growth and promotes differentiation of pancreatic endocrine cells

Limitations in cell proliferation are a key barrier to reprogramming differentiated cells to pluripotent stem cells, and conversely, acquiring these limitations may be important to establish the differentiated state. The pancreas, and beta cells in particular have a low proliferative potential, which limits regeneration, but how these limitations are established is largely unknown. Understanding proliferation potential is important for the safty of cell replacement therapy with cell products made from pluripotent stem cell which have unlimited proliferative potential. Here we test a novel hypothesis, that these limitations are established through limitations in S-phase progression. We used a stem cell-based system to expose differentiating stem cells to small molecules that interfere with cell cycle progression either by inducing G1 arrest, impairing S-phase entry, or S-phase completion. Upon release from these molecules, we determined growth potential, differentiation and function of insulin-producing endocrine cells both in vitro and after grafting in vivo. We found that the combination of G1 arrest with a compromised ability to complete DNA replication promoted the differentiation of pancreatic progenitor cells towards insulin-producing cells, improved the stability of the differentiated state, and protected mice from diabetes without the formation of cystic growths. Therefore, a compromised ability to enter S-phase and replicate the genome is a functionally important property of pancreatic endocrine differentiation, and can be exploited to generate insulin-producing organoids with predictable growth potential after transplantation.

cell biology↗

bioRxiv2018

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion

A rare loss-of-function variant p.Arg138* in SLC30A8 encoding the zinc transporter 8 (ZnT8) enriched in Western Finland protects against type 2 diabetes (T2D). We recruited relatives of the identified carriers and showed that protection was associated with better insulin secretion due to enhanced glucose responsiveness and proinsulin conversion, especially compared with individuals matched for the genotype of a common T2D risk variant in SLC30A8, p.Arg325. In genome-edited human IPS-derived {beta}-like cells, we establish that the p.Arg138* variant results in reduced SLC30A8 expression due to haploinsufficiency. In human {beta}-cells loss of SLC30A8 leads to increased glucose responsiveness and reduced KATP channel function, which was also seen in isolated islets from carriers of the T2D-protective allele p.Trp325. These data position ZnT8 as an appealing target for treatment aiming at maintaining insulin secretion capacity in T2D.

genetics↗